WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb...

Published on 16 Feb 2025 on Benzinga

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Photo via WeRide

Read the rest of the article

Start tracking your investments with Statfolio

Insperity, Inc. NSP reported impressive fourth-quarter 2024 results, wherein earnings and revenue...

Zacks · via Yahoo Finance 17 Feb 2025

Insperity, Inc. (NYSE:NSP – Get Free Report) has received a consensus rating of “Reduce” from the...

ETF DAILY NEWS 17 Feb 2025

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? P...

Benzinga 16 Feb 2025

The investors in Insperity, Inc.'s (NYSE:NSP) will be rubbing their hands together with glee toda...

Simply Wall St. · via Yahoo Finance 14 Feb 2025

Insperity, Inc. (NYSE:NSP – Free Report) – Stock analysts at Roth Capital issued their FY2026 ear...

ETF DAILY NEWS 14 Feb 2025

Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Insperity, Inc. (NYSE:NS...

ETF DAILY NEWS 10 Feb 2025

Insperity, Inc. (NYSE:NSP), might not be a large cap stock, but it saw significant share price mo...

Simply Wall St. · via Yahoo Finance 24 Dec 2024

Insperity Inc (NYSE:NSP) is set to release its Q3 2024 earnings on Oct 31, 2024. The consensus...

GuruFocus.com · via Yahoo Finance 30 Oct 2024

Insperity, Inc. NSP reported mixed first-quarter 2024 results, wherein earnings surpassed the Zac...

Zacks via Yahoo Finance 9 May 2024

The quarterly results for Insperity, Inc. (NYSE:NSP) were released last week, making it a good ti...

Simply Wall St. via Yahoo Finance 4 May 2024